Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Inflammation, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Urogenital Diseases, breast disorder, breast neoplasm, endocrine system disorder, female reproductive system disorder, gonadal disorder, neoplasm, ovarian disorder, primary ovarian failure, skin disorder, triple-negative breast carcinoma	Not yet recruiting	Not stated	2026-04-14		NCT07527819

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chris O'Brien Lifehouse	1
Eastern Health	8
Hunter Medical Research Institute (HMRI)	2
Integrated Haematology and Oncology Network	2
Lyell McEwin Hospital	1
Mater Hospital Sydney	1
Monash Health	6
Peter MacCallum Cancer Centre, Australia	48
Royal Melbourne Hospital, Australia	3
Sir Charles Gairdner Hospital	4

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chris O'Brien Lifehouse	Camperdown	Australia	46
Eastern Health	Box Hill	Australia	15
Icon Cancer Centre	Hobart	Australia	2
Lyell McEwin Hospital	Adelaide	Australia	8
Mater Hospital Sydney	Sydney	Australia	2
Monash Health	Clayton	Australia	74
Peter MacCallum Cancer Centre	Melbourne	Australia	149
Royal Melbourne Hospital	Melbourne	Australia	7
Sir Charles Gairdner Hospital	Nedlands	Australia	2